Search

Now showing items 1-10 of 41

Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial: FOR: There is lack of clarity on a number of key issues.

Manchanda, R; Menon, U (2016-02)

DETECTION OF NON-OVARIAN CANCERS ON PHASE 2 OF THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UKFOCSS)

Philpott, S; Rizzuto, I; Fraser, L; Manchanda, R; Hadwin, R; Burnell, M; Mackay, S; Skates, S; Menon, U; Jacobs, I;... (2013-10)

A quantitative performance study of two automatic methods for the diagnosis of ovarian cancer.

Vázquez, MA; Mariño, IP; Blyuss, O; Ryan, A; Gentry-Maharaj, A; Kalsi, J; Manchanda, R; Jacobs, I; Menon, U; Zaikin, A (2018-09)

We present a quantitative study of the performance of two automatic methods for the early detection of ovarian cancer that can exploit longitudinal measurements of multiple biomarkers. The study is carried out for a subset ...

Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population

Blyuss, O; Burnell, M; Ryan, A; Gentry-Maharaj, A; Marino, IP; Kalsi, J; Manchanda, R; Timms, JF; Parmar, M; Skates, SJ;... (2018-10-01)

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History-Based Testing

Manchanda, R; Legood, R; Burnell, M; McGuire, A; Raikou, M; Loggenberg, K; Wardle, J; Sanderson, S; Gessler, S; Side, L;... (2015-01)

Risk Reducing Salpingectomy and Delayed Oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK

Chandrasekaran, D; Menon, U; Evans, G; Crawford, R; Saridogan, E; Jacobs, C; Tischkowitz, M; Brockbank, E; Kalsi, J; Jurkovic, D;... (Springer Verlag (Germany), 2015-07-16)

Risk-reducing-salpingectomy and Delayed-Oophorectomy (RRSDO) is being proposed as a two-staged approach in place of RRSO to reduce the risks associated with premature menopause in high-risk women. We report on the ...

Importance of serial CA125 measurements over an absolute cut-off value for the detection of asymptomatic ovarian cancer in high-risk patients.

Dilley, J; Manchanda, R; Johnson, M; Rosenthal, AN; Gessler, S; Menon, U (2016-05)

1
2
3
4
. . .
5

Search

Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial: FOR: There is lack of clarity on a number of key issues.

DETECTION OF NON-OVARIAN CANCERS ON PHASE 2 OF THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UKFOCSS)

A quantitative performance study of two automatic methods for the diagnosis of ovarian cancer.

Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History-Based Testing

Risk Reducing Salpingectomy and Delayed Oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK

Importance of serial CA125 measurements over an absolute cut-off value for the detection of asymptomatic ovarian cancer in high-risk patients.

Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study

Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population

Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women

Search

Filters

Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial: FOR: There is lack of clarity on a number of key issues.

DETECTION OF NON-OVARIAN CANCERS ON PHASE 2 OF THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UKFOCSS)

A quantitative performance study of two automatic methods for the diagnosis of ovarian cancer.

Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History-Based Testing

Risk Reducing Salpingectomy and Delayed Oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK

Importance of serial CA125 measurements over an absolute cut-off value for the detection of asymptomatic ovarian cancer in high-risk patients.

Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study

Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population

Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women